C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/211, 167/242
C07D 495/04 (2006.01) A61K 31/38 (2006.01) A61K 31/395 (2006.01)
Patent
CA 2022119
Carbonic anhydrase inhibitors of the thieno- [2,3-b]thiopyran-2-sulfonamide type with a substituted- alkyl-amino group in the 4-position are topically effective in lowering intraocular pressure; the inhibitors are compounds of formula (I): Image wherein: X is -S-, or -0-; m is 0, 1 or 2 n is 0, 1 or 2 R is hydrogen or R1, R1 is 1) C2-7-alkene, 2) C2-7-alkyne, 3) C1-5 alkyl having 1, 2 or 3 substituents wherein the substituents are independently: a) halogen; b) hydroxy; c) -NR6R7 wherein R6 and R7 are independently: i) hydrogen, ii) C1-3 alkyl, iii) -CO-C1-3 alkyl, or iv) R6 and R7 taken together with the nitrogen to which they are attached represent a saturated heterocycle of 5-7 members which may include a second hetero group selected from 0, S, S0, or S02; d) -S-C1-3-alkyl; (0)n e) -CN; f) C1-3-alkoxy, g) -SH, h) C1-3-alkoxycarbonyl, O " i) -C-C1-3 alkyl, 0 " j) -CNR6r7 or k) C3-6 cycloalkyl; R2 is 1) hydrogen, 2) -CN, 3) phenyl-C1-3 alkyl, wherein the phenyl is either unsubstituted or substituted with one or more of a) hydroxy, b) C1-3-alkoxy, c) R6R7NC1-5-alkyl; or 4) C1-5 alkyl; and R3 and R4 are independently: 1) hydrogen, 2) C1-5 alkyl, either unsubstituted or substituted with one or more of a) halogen, b) hydroxy, c) -NR8R9, wherein R8 and R9 are independently i) hydrogen, ii) C1-5 alkyl, unsubstituted or substituted with phenyl, wherein the phenyl is unsubstituted or substituted with C1-3 alkoxy, halogen, or di(C1-3- alkyl)-amino; d) phenyl, unsubstituted or substituted with one or more of i) hydroxy, ii) C1-3 alkoxy, iii) C1-3 alkyl-NR10R11, wherein R10 and R11 are independently hydrogen or C1-5 alkyl, 3) phenyl, either unsubstituted or substituted with i) hydroxy, ii) C1-3 alkoxy, iii) C1-5 alkyl-NR10R11, iv) halo, 4) aromatic heterocycle of 5 or 6 members unsubstituted or substituted with C1-3 alkyl -NR10R11, R3 and R4 taken together represent methylene: with the proviso that R1 is not 2-hydroxy-2-methyl-1- propyl if R, R2, R3 and R4 are all hydrogen and n is 2.
Baldwin John J.
Ponticello Gerald S.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Substituted aromatic sulfonamides as antiglaucoma agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted aromatic sulfonamides as antiglaucoma agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted aromatic sulfonamides as antiglaucoma agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1428142